All > Massachusetts Investigators

Michael S Stalvey, MD

University of Massachusetts Medical School

Worcester, Massachusetts - 01655 (508-856-1767)

Umms/Ummhc

Worcester, Massachusetts - 01655 (508-856-4280)

CLINICAL TRIALS 2
CONDITIONS3
INTERVENTIONS2
SINCE2008

Phase 1/2 Safety and Efficacy Study of AAV-RPE65 Vector to Treat Leber Congenital Amaurosis

December 2008 - December 2026

Growth Hormone Therapy for Wasting in Cystic Fibrosis

November 2008 - January 2012

Cystic Fibrosis

Fibrosis

Blindness

Nutropin Aq

Raav2-Cb-Hrpe65

Learn about TrialX Patient Recruitment services

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

Michael S Stalvey, MD

University of Massachusetts Medical School

Umms/Ummhc

Massimo Loda, MD

Suzanne Shusterman

Patrick Y. Wen, MD

Lewis B. Silverman, MD

Kay Kehoe, Coordinator

Jennifer Brown, MD

Rachel A. Freedman

Edwin P. Alyea, MD

F. Stephen Hodi, MD

Beth A. Overmoyer, MD, FACP